These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 22535374)
1. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. De Boeck A; Pauwels P; Hensen K; Rummens JL; Westbroek W; Hendrix A; Maynard D; Denys H; Lambein K; Braems G; Gespach C; Bracke M; De Wever O Gut; 2013 Apr; 62(4):550-60. PubMed ID: 22535374 [TBL] [Abstract][Full Text] [Related]
2. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination. Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199 [TBL] [Abstract][Full Text] [Related]
3. Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity. Nakata S; Tanaka H; Ito Y; Hara M; Fujita M; Kondo E; Kanemitsu Y; Yatabe Y; Nakanishi H Int J Oncol; 2014 Oct; 45(4):1583-93. PubMed ID: 25017791 [TBL] [Abstract][Full Text] [Related]
4. Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer. Beji A; Horst D; Engel J; Kirchner T; Ullrich A Clin Cancer Res; 2012 Feb; 18(4):956-68. PubMed ID: 22142822 [TBL] [Abstract][Full Text] [Related]
6. HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver. Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D Acta Oncol; 2015 Apr; 54(4):480-6. PubMed ID: 25601452 [TBL] [Abstract][Full Text] [Related]
7. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854 [TBL] [Abstract][Full Text] [Related]
8. Endothelial Cells Promote Colorectal Cancer Cell Survival by Activating the HER3-AKT Pathway in a Paracrine Fashion. Wang R; Bhattacharya R; Ye X; Fan F; Boulbes DR; Ellis LM Mol Cancer Res; 2019 Jan; 17(1):20-29. PubMed ID: 30131447 [TBL] [Abstract][Full Text] [Related]
9. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584 [TBL] [Abstract][Full Text] [Related]
10. The neuregulin-I/ErbB signaling system in development and disease. Britsch S Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235 [TBL] [Abstract][Full Text] [Related]
12. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166 [TBL] [Abstract][Full Text] [Related]
13. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines. Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110 [TBL] [Abstract][Full Text] [Related]
14. Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates. Razumienko EJ; Scollard DA; Reilly RM J Nucl Med; 2012 Dec; 53(12):1943-50. PubMed ID: 23096164 [TBL] [Abstract][Full Text] [Related]
15. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
16. HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer. Bogoevska V; Wolters-Eisfeld G; Hofmann BT; El Gammal AT; Mercanoglu B; Gebauer F; Vashist YK; Bogoevski D; Perez D; Gagliani N; Izbicki JR; Bockhorn M; Güngör C Oncogene; 2017 Apr; 36(17):2394-2404. PubMed ID: 27941874 [TBL] [Abstract][Full Text] [Related]
17. ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Ebbing EA; Medema JP; Damhofer H; Meijer SL; Krishnadath KK; van Berge Henegouwen MI; Bijlsma MF; van Laarhoven HW Oncotarget; 2016 Mar; 7(9):10243-54. PubMed ID: 26863569 [TBL] [Abstract][Full Text] [Related]
18. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation. De Potter IY; Poumay Y; Squillace KA; Pittelkow MR Exp Cell Res; 2001 Dec; 271(2):315-28. PubMed ID: 11716544 [TBL] [Abstract][Full Text] [Related]
19. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547 [TBL] [Abstract][Full Text] [Related]
20. HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. Soler M; Mancini F; Meca-Cortés O; Sánchez-Cid L; Rubio N; López-Fernández S; Lozano JJ; Blanco J; Fernández PL; Thomson TM Int J Cancer; 2009 Dec; 125(11):2565-75. PubMed ID: 19530240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]